Arizona State Retirement System Arcus Biosciences, Inc. Transaction History

Arizona State Retirement System

$15.6 Billion
Q3 2024

A detailed history of Arizona State Retirement System transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Arizona State Retirement System holds 14,405 shares of RCUS stock, worth $223,277. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,405

Previous 13,990 2.97%

Holding current value

$223,277

Previous $213,000 3.29%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$13.69 - $18.01 $5,681 - $7,474	415 Added 2.97%	14,405 $220,000
Q2 2024 Aug 05, 2024	BUY	$14.59 - $18.48 $9,016 - $11,420	618 Added 4.62%	13,990 $213,000
Q1 2024 May 07, 2024	SELL	$14.83 - $20.18 $2,461 - $3,349	-166 Reduced 1.23%	13,372 $252,000
Q4 2023 Jan 24, 2024	BUY	$13.43 - $19.63 $107 - $157	8 Added 0.06%	13,538 $258,000
Q3 2023 Nov 06, 2023	BUY	$17.62 - $23.54 $21,602 - $28,860	1,226 Added 9.96%	13,530 $242,000
Q2 2023 Aug 01, 2023	SELL	$16.97 - $22.03 $4,819 - $6,256	-284 Reduced 2.26%	12,304 $249,000
Q1 2023 Apr 27, 2023	BUY	$15.96 - $23.15 $5,921 - $8,588	371 Added 3.04%	12,588 $229,000
Q4 2022 Feb 07, 2023	BUY	$19.7 - $35.71 $10,303 - $18,676	523 Added 4.47%	12,217 $252,000
Q3 2022 Nov 07, 2022	BUY	$23.23 - $30.07 $3,228 - $4,179	139 Added 1.2%	11,694 $306,000
Q2 2022 Jul 28, 2022	BUY	$17.23 - $37.73 $19,142 - $41,918	1,111 Added 10.64%	11,555 $293,000
Q1 2022 May 04, 2022	SELL	$28.92 - $41.83 $3,615 - $5,228	-125 Reduced 1.18%	10,444 $330,000
Q4 2021 Feb 04, 2022	SELL	$31.38 - $48.47 $2,102 - $3,247	-67 Reduced 0.63%	10,569 $428,000
Q3 2021 Nov 12, 2021	BUY	$26.93 - $37.68 $1,077 - $1,507	40 Added 0.38%	10,636 $371,000
Q2 2021 Aug 02, 2021	SELL	$22.75 - $35.77 $38,424 - $60,415	-1,689 Reduced 13.75%	10,596 $291,000
Q1 2021 May 06, 2021	BUY	$26.16 - $41.39 $1,308 - $2,069	50 Added 0.41%	12,285 $345,000
Q4 2020 Jan 28, 2021	BUY	$17.0 - $32.36 $18,428 - $35,078	1,084 Added 9.72%	12,235 $318,000
Q3 2020 Nov 05, 2020	BUY	$17.14 - $25.47 $48,231 - $71,672	2,814 Added 33.75%	11,151 $191,000
Q2 2020 Aug 04, 2020	BUY	$13.97 - $36.56 $116,467 - $304,800	8,337 New	8,337 $206,000

Others Institutions Holding RCUS

# of Institutions

200

Shares Held

51.5M

Call Options Held

236K

Put Options Held

141K

View Full List

About Arcus Biosciences, Inc.

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.12B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

More about RCUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.

Account

Arizona State Retirement System Arcus Biosciences, Inc. Transaction History